SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-04-210340
Filing Date
2004-12-09
Accepted
2004-12-09 16:25:20
Documents
8
Period of Report
2004-12-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 27385
2 FOURTH AMENDMENT OF THE AMGEN RETIREMENT AND SAVINGS PLAN dex101.htm EX-10.1 17419
3 FIFTH AMENDMENT TO THE AMGEN INC. CHANGE OF CONTROL SEVERANCE PLAN dex102.htm EX-10.2 7304
4 FIRST AMENDMENT TO THE AMGEN INC. EXECUTIVE INCENTIVE PLAN dex103.htm EX-10.3 3191
5 AMENDED AND RESTATED 1991 EQUITY INCENTIVE PLAN dex104.htm EX-10.4 76103
6 AMGEN INC. PERFORMANCE AWARD PROGRAM dex105.htm EX-10.5 37355
7 PERFORMANCE UNIT AGREEMENT dex106.htm EX-10.6 14709
8 AMGEN INC. DIRECTOR EQUITY INCENTIVE PROGRAM dex107.htm EX-10.7 31078
  Complete submission text file 0001193125-04-210340.txt   217312
Mailing Address ONE AMGEN CENTER DRIVE MAIL STOP 27-3-C THOUSAND OAKS CA 91320-1799
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320-1799 805-447-1000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-12477 | Film No.: 041193655
SIC: 2836 Biological Products, (No Diagnostic Substances)